European Biotech Acquisition - Warrants (06/03/2026) Other Current Assets

The latest other current assets for EBACW is $48K as of December 2022. That compares with $48K in the prior-year period — down 0.1% year over year. Investors often review this figure alongside European Biotech Acquisition - Warrants (06/03/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, EBACW's other current assets moved from $48K to $48K — a 0.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in European Biotech Acquisition - Warrants (06/03/2026)'s operating scale or balance-sheet position.

A other current assets figure of $48K for EBACW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting EBACW's other current assets ($48K), review year-over-year change from $48K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.